Columbia neuroscientists have identified a genetic mutation that fends off Alzheimer's in people at high risk and could lead to a new way to protect people from the disease.
With funding from the Ultra-rare Gene-based Therapy Network, scientists at Columbia and the n-Lorem Foundation will create tailor-made gene-based therapies for people with rare forms of ALS.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
Racial disparities in stroke are due primarily to higher rates and poorer treatment of hypertension, diabetes, and high cholesterol among black Americans.
Researchers have identified two types of neurons that enable the spinal cord to control skilled forelimb movement. The findings could lead to new ways to treat movement disorders.
Neurologist Scott A. Small participated in a Kavli Foundation roundtable on the link between the brain's ability to make new cells and age-related memory loss.